Collplant Biotechnologies Ltd. - (OPHI) closed at $3.21 on November 19, 2026, down 5.6% from the previous close, on volume of 38,717 shares (30-day average 128,183).
Data as of November 19, 2026.
No headlines found.
No press releases found.
No news found.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.
Collplant Biotechnologies Ltd. - trades on the NASDAQ stock market under the symbol OPHI.
As of November 19, 2026, OPHI stock price declined to $3.21 with 38,717 million shares trading.
OPHI has a market cap of $9.87 million. This is considered a Sub-Micro Cap stock.
OPHI support price is $3.06 and resistance is $3.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OPHI shares will trade within this expected range on the day.